eli lilly small molecule glp 1 Lilly's orforglipron: a new oral GLP-1 therapy | Thomas Fessard posted on the topic Eli Lilly's New $299 Month-Long

Experienced telehealth and obesity physicians support access-maximizing asynchronous care pathways and evidence-based lab flows

However, the medications it prescribes are compounded formulations that have not undergone FDA clinical trials

Shedding may begin 2 to 3 months after rapid weight loss or under-eating starts, peak over the following weeks, and then gradually settle as nutrition and body stress improve

Eligible patients in Maryland and Delaware may receive in-person or telehealth care based on their location and clinical needs Some patients notice changes in appetite during the first few doses, while others require gradual dose escalation before experiencing a meaningful effect